AMAM
AMBRX BIOPHARMA INC-ADR
$28
Earnings Summary
Revenue | $0.05Mn |
Net Profits | $-22.99Mn |
Net Profit Margins | -43375.47% |
Highlights
AMBRX BIOPHARMA INC-ADR’s revenue fell -97.64% since last year same period to $0.05Mn in the Q3 2023. On a quarterly growth basis, AMBRX BIOPHARMA INC-ADR has generated -95.28% fall in its revenue since last 3-months.
AMBRX BIOPHARMA INC-ADR’s net profit fell -73.46% since last year same period to $-22.99Mn in the Q3 2023. On a quarterly growth basis, AMBRX BIOPHARMA INC-ADR has generated -28.96% fall in its net profits since last 3-months.
AMBRX BIOPHARMA INC-ADR’s net profit margin fell -7247.34% since last year same period to -43375.47% in the Q3 2023. On a quarterly growth basis, AMBRX BIOPHARMA INC-ADR has generated -2632.56% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the AMBRX BIOPHARMA INC-ADR post its latest quarter earnings
EPS Estimate Current Year | -0.05 |
Highlights
AMBRX BIOPHARMA INC-ADR’s earning per share (EPS) estimates for the current year stand at -0.05.
Key Ratios
Key ratios of the AMBRX BIOPHARMA INC-ADR post its Q1 2024 earnings
Earning Per Share (EPS) | 0 |
Highlights
AMBRX BIOPHARMA INC-ADR’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2024. This indicates that the AMBRX BIOPHARMA INC-ADR has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-04-23 | -0.05 | 0 | 100% |
₹0 US Stocks a/c Opening Fee